Navigation Links
The proof's in the bubbles
Date:3/1/2010

Reston, Va.An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

"We hope this technique might be helpful for the early detection of disease," said Juergen K. Willmann, M.D., lead author of the study and assistant professor of radiology at Stanford University School of Medicine. "It may help save lives by finding cancersuch as breast, ovarian or pancreatic cancerin the very early stages, when it is still curable."

In the study, researchers intravenously injected microbubblesgas-filled spheres small enough to travel through vesselsinto mice with cancers. The microbubbles, which were paired with a new peptide (a molecule that consists of a chain of amino acids), were designed to travel through the vascular system and attach to integrina well-characterized molecular marker that acts as a "red flag" for tumor vessel growth, or angiogenesis. Tumor vessel growth occurs when active tumor cells create certain pathways to provide the tumor with a sufficient supply of oxygen, nutrients and other factors needed for growth.

Once the gas-filled microbubbles seek out the cancers and attach to their vessel walls, they send out strong signals that are picked up by standard clinical ultrasound scanners. The imaging signals produced by the microbubbles are reflected back to the ultrasound transducer and illuminate the areas that outline the tumor, thus providing researchers with a sonogram of tumor vessel growth on a molecular level.

"Ultrasound holds great promise for the application of molecular imaging because it is widely available, relatively inexpensive and safe. There is no exposure to radiation and repetitive imaging is not a concern," said Dr. Willmann. "Furthermore, the targeted microbubbles have great potential for translation from bench to bedsidewhich will be explored in future studies," said Sanjiv Gambhir, M.D., Ph.D., director of the molecular imaging program at Stanford.

Contrast-enhanced ultrasound can be used to image blood perfusion in organs, to measure blood flow rate in the heart and other organs and to perform other applicationssuch as characterization of focal lesions in the liver. Current interest is focused on modifying contrast agents to make them specifically useful for molecular imaging. The microbubbles, paired with the new peptide that binds to tumor vessel cells as studied in the current research, may be more effective than antibody molecules, which are time-intensive to produce, are costly and may cause adverse reactions in patients.

Noninvasive imaging strategies such as the one described in the JNM study may be particularly helpful for diagnosing cancer in its earliest stages as well as for developing therapeutic agents to treat cancer and monitoring whether treatment is working.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Cancer cells spread by releasing bubbles, according to an MUHC study
2. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
3. Im forever imploding bubbles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 05, 2016 , ... The talus is the part ankle ... falls, or traffic accidents can cause the talus bone to be fractured, and a ... In a first-of-its-kind procedure using 3D printing technology, internationally renowned orthopedic surgeon Dr. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... announces the Everlasting Glove, a sports invention that aids in the improvement of ... Manufacturing industry is worth $9 billion," says Scott Cooper, CEO and Creative Director ...
(Date:5/4/2016)... ... 2016 , ... Trinity Health today launched its inaugural Innovation ... at improving care and reducing readmission rates for patients who are dually eligible ... is to drive innovation that transforms our ministry and our industry to be ...
(Date:5/4/2016)... AZ (PRWEB) , ... May 04, 2016 , ... ... Annual Technology & Business Conference. The conference opened on Tuesday with Frank Luntz, ... discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model solution ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Level 10 Head ... her verbal commitment to the University of Arizona for the fall of 2019. ... decision last month. Brovedani’s commitment to the GymCats came from her connection with the ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016 According ... Size, Share, Development, Growth and Demand Forecast to 2022 ... Field Strength (High Field, Very High Field, Low to ... Head and Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and ... magnetic resonance imaging (MRI) market was valued at $5,351.7 ...
(Date:5/3/2016)... 3, 2016 Norgine ... sie einen entscheidenden Meilenstein durch diese Veröffentlichung ... zum Handeln, um Patientenresultate  bei Verdauungs- und ... Fortschritten im Verständnis der Hepatischen Enzephalopathie bei ... für Hepatische Enzephalopathie in der Öffentlichkeit zu ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... today announced data from the first cohort of ... trial (the OVATION Study) combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  In the first three patients ...
Breaking Medicine Technology: